Naturhouse Health, S.A. reported group earnings results for the nine months of 2015. For the year, the group's sales have increased to EUR 74.1 million as a result of the improvement in the international business, which has registered growth of 2.8% led by France (+4.5%) and Poland (+23.2%), and the slowdown in the decline of the Italian and Spanish markets. Meanwhile, EBITDA stands at EUR 27 million, 0.5% higher than the amount recorded in the same period last year, due to the overall improvement in the business and the operational efficiency measures continuously implemented by the company.

With this figure, Naturhouse registers an EBITDA margin of 36.4%, which is higher than for the same period in 2014 and above the upper threshold of the group's target range (30%/35%) for fiscal years 2015 and 2016, while also being the high in the industry. Net income is up 1.3% to EUR 18.7 million, due to a general improvement in the business alongside lower financial costs and the 35% increase of the contribution made by Ichem, in which Naturhouse has holdings.